Johnson & Johnson (NYSE:JNJ) is among the stocks on Jim Cramer’s game plan as he shared his take on the market post Iran-U.S. ceasefire talks. Cramer noted that it has become his favorite drug stock instead of Eli Lilly, as he said: Now, my favorite drug stock reports next week, too, and that’s not Lilly anymore. It’s Johnson & Johnson. We own this one for the Charitable Trust, and I think we’re going to hear that it has the most blockbusters and the best pipeline in the industry. This is a company transf ...